Schroder Investment Management Group’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-5,400
Closed -$73K – 1330
2020
Q1
$73K Hold
5,400
– – ﹤0.01% 1201
2019
Q4
$130K Hold
5,400
– – ﹤0.01% 1194
2019
Q3
$114K Sell
5,400
-5,400
-50% -$112K ﹤0.01% 1181
2019
Q2
$238K Buy
10,800
+5,400
+100% +$125K ﹤0.01% 1134
2019
Q1
$128K Hold
5,400
– – ﹤0.01% 1093
2018
Q4
$120K Hold
5,400
– – ﹤0.01% 1120
2018
Q3
$141K Hold
5,400
– – ﹤0.01% 1156
2018
Q2
$146K Hold
5,400
– – ﹤0.01% 1176
2018
Q1
$140K Hold
5,400
– – ﹤0.01% 1184
2017
Q4
$149K Buy
+5,400
New +$143K ﹤0.01% 1224
2017
Q2
– Sell
-9,201
Closed -$251K – 1339
2017
Q1
$251K Buy
+9,201
New +$235K ﹤0.01% 1092

Other funds holding TBI

Schroder Investment Management Group's TBI Position: Q2 2020 in Review

Schroder Investment Management Group sold out of Trueblue (TBI) in Q2 2020, closing a stake of 5,400 shares — an estimated $73K sold.

Schroder Investment Management Group first reported a position in TBI in Q1 2017 and held it in 11 quarters. The position peaked at $251K in Q1 2017. 160 funds tracked by Wall St. Rank hold TBI as of Q2 2020.

  • Schroder Investment Management Group reported no remaining Trueblue position as of Q2 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 5,400 Trueblue shares in Q2 2020, an estimated $73K.
  • Schroder Investment Management Group first reported a position in Trueblue in Q1 2017 and held it in 11 quarters.
  • Schroder Investment Management Group's Trueblue position peaked at $251K in Q1 2017.
  • 160 funds tracked by Wall St. Rank held Trueblue as of Q2 2020.

Based on Schroder Investment Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.